Assessment of Knowledge, Attitudes, and Vaccination Practices Regarding the New RSV Vaccine among Health Professionals in Greece

Author:

Papagiannis Dimitrios1ORCID,Tiganis Nikolaos2,Kotsiou Ourania S.3ORCID,Lampropoulos Ioannis C.4ORCID,Fradelos Evangelos C.5ORCID,Malli Foteini4ORCID,Gourgoulianis Konstantinos I.6ORCID

Affiliation:

1. Public Health & Adults Immunization Laboratory, School of Health Sciences, Faculty of Nursing, University of Thessaly, 41110 Larissa, Greece

2. Primary Health Care Postgraduate Program, University of Thessaly, 41500 Larissa, Greece

3. Department of Human Pathophysiology, Faculty of Nursing, University of Thessaly, 41500 Larissa, Greece

4. Respiratory Disorders Laboratory, Faculty of Nursing, University of Thessaly, 41110 Larissa, Greece

5. Laboratory of Clinical Nursing, Department of Nursing, University of Thessaly, 41500 Larissa, Greece

6. Department of Respiratory Medicine, School of Health Sciences, Faculty of Medicine, University of Thessaly, 41500 Larissa, Greece

Abstract

The introduction of a new vaccine into immunization programs represents a significant advancement in the global effort to combat vaccine-preventable diseases. Data from the World Health Organization support that immunization prevents between 2 and 3 million deaths each year across various diseases, underscoring its pivotal role in global health. The present study aims to assess the knowledge, attitudes, and anticipated vaccination practices among health professionals in Central Greece in response to the potential introduction of new Respiratory Syncytial Virus (RSV) vaccination guidelines by the National Vaccines Committee. Among the 450 health professionals solicited for the study, 219 provided responses, yielding a response rate of approximately 55%. A substantial majority (70.3%) accurately identified the vaccine’s current availability, and 62.1% were aware of the current recommendation for RSV vaccination in pregnant women. In response to whether health professionals support the inclusion of an RSV vaccine in the national vaccination program if it becomes commercially available and is recommended by the Greek National Immunization Program, general practitioners showed the most support, with an average score of 4.86 (95% CI, 4.69–5.00), followed by pediatricians at 4.76 (95% CI, 4.63–4.89), pulmonologists at 4.68 (95% CI, 4.36–5.00), and obstetricians at 4.33 (95% CI, 3.95–4.71). Concerning general opinions on vaccinations, a high level of agreement was noted among the majority of health professionals, excluding nurses. Pharmacists recorded the highest agreement, with a perfect score of 5 (CI, 5.00–5.00), followed closely by pediatricians at 4.99 (CI, 4.97–5.00), GPs at 4.95 (CI, 4.85–5.00), pulmonologists at 4.93 (CI, 4.83–5.00), obstetricians at 4.74 (CI, 4.42–5.00), and nurses at 3.80 (CI, 3.06–4.54). A tailored approach to education is needed to ensure that healthcare professionals can communicate more effectively about RSV risks and vaccination benefits, fostering a proactive stance towards disease prevention and patient care. In essence, our study underscores the importance of knowledge in shaping a compassionate and responsive healthcare environment, ready to meet the challenges of RSV head-on.

Publisher

MDPI AG

Reference37 articles.

1. World Health Organization (2009). State of the World’s Vaccines and Immunization, World Health Organization. [3rd ed.].

2. A newly discovered human pneumovirus isolated from young children with respiratory tract disease;Groen;Nat. Med.,2001

3. WHO (2024, February 15). Respiratory Syncytial Virus (RSV). Available online: https://www.who.int/teams/immunization-vaccines-and-biologicals/diseases/respiratory-syncytial-virus-(rsv).

4. Respiratory syncytial virus infections within families;Hall;N. Engl. J. Med.,1976

5. Respiratory-syncytial-virus infections, reinfections and immunity. A prospective, longitudinal study in young children;Henderson;N. Engl. J. Med.,1979

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3